Project Grant HT94252510889
- The U.S. Defense Health Agency awarded a $1.2M Project Grant to HMH Hospitals Corporation (doing business as Hackensack University Medical Center) under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to investigate the mechanisms of impaired swallowing, speech, and voice in Parkinson's disease over a 3-year period from July 1, 2023 to June 30, 2026. As a not-for-profit healthcare organization, HMH Hospitals Corporation has a history of...
- This Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $708,399.00 to HMH Hospitals Corporation, doing business as Hackensack University Medical Center, to investigate the therapeutic implications of TN BC-specific ETV6 rearrangements, particularly related to chemoresistance and immune evasion. The award began on March 1, 2024 and is scheduled to be completed by February 28, 2027. Hackensack University Medical...
- The U.S. Defense Health Agency awarded a $4,626,921 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period of August 1, 2025 to July 31, 2028, will fund research to elucidate the role of the neurovascular unit and related structural and functional neurological sequelae after exposure to repeated blast. This research aims to transform...
- The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
- The Defense Health Agency awarded Rutgers, The State University a $471,000 project grant under the Military Medical Research and Development program (CFDA 12.420) to develop new therapeutic strategies for chemo brain in ovarian cancer survivors. The grant period runs from July 1, 2023 through June 30, 2027 in New Brunswick, New Jersey. Through its Research Financial Services division, Rutgers will leverage its expertise in bioengineering and disease research to investigate medical solutions...
- This federal Project Grant award for $1,607,403.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a longitudinal study on monitoring cognitive changes in older veterans using telehealth-based computerized neuropsychological assessments. The award was granted to the East Bay Institute for Research & Education Inc., a non-profit organization in Mather, California, to conduct this 3-year research project from March 1,...
- The Defense Health Agency awarded a $250,000 Project Grant to Rutgers, The State University of New Jersey to conduct research titled "BOOSTING MYELINATION USING VISUAL FLICKER IN THE ACUTE CUPRIZONE INTOXICATION MODEL". The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate medical solutions for the battlefield through basic, applied, and advanced biomedical research. The project is scheduled to be completed...
- The Defense Health Agency awarded a $7,694,338 Project Grant on September 30, 2025 to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LIVING WITH VIOLENCE-RELATED BRAIN INJURY: OPTIMIZING COGNITIVE AND PSYCHOLOGICAL WELLNESS THROUGH THE LIVEWELL BRAIN HEALTH STUDY," supports advanced biomedical research to transform healthcare for military service members, veterans, and the public through...
- This Project Grant award, totaling $10,009,861.88, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports two primary activities: A randomized controlled multisite trial evaluating a portable near-infrared hematoma imager for the detection of intracranial hemorrhage in acute care settings. This trial will evaluate the efficacy and feasibility of this medical imaging device. A randomized controlled multisite trial...
- Rutgers The State University Of New Jersey, doing business as Rbhs-School Of Nursing, was awarded a $785,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund development of new therapeutic strategies for chemo brain in ovarian cancer survivors from July 1, 2023 through June 30, 2027. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $4,364,915.00 to HMH Hospitals Corporation (doing business as Hackensack University Medical Center) to conduct a clinical trial evaluating the efficacy of a building emotional self-awareness teletherapy intervention for improving psychological health in service members with brain injury. The award period runs from September 30, 2025 to September 29, 2029, and the project will take place in Edison, NJ. As a major medical institution, HMH Hospitals Corporation has an extensive portfolio of federal research grants supporting advanced investigations across areas such as infectious disease, cancer, and neuroscience.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $4.4m | 8/25/25 |